Loeb D D, Tian R, Gulya K J
McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison 53706, USA.
J Virol. 1996 Dec;70(12):8684-90. doi: 10.1128/JVI.70.12.8684-8690.1996.
The initial aim of this study was to examine the role of complementarity between the plus-strand primer and the minus-strand DNA template for translocation of the plus-strand primer in hepadnaviral replication. We show that when a 5-nucleotide substitution was placed in either DR1 or DR2, translocation of the primer at a detectable level did not occur. Placing the mutation in both DR1 and DR2 did not restore primer translocation, which indicates that complementarity is not the sole determinant for primer translocation. These mutants, in which primer translocation has been inhibited, have been additionally informative. The mutation in DR1 led to efficient synthesis of plus-strand DNA, albeit primed in situ. In contrast, the mutation in DR2 resulted in a reduction in the amount of plus-strand DNA synthesized per unit of minus-strand DNA. These findings were interpreted as indicating that a mutation at DR2, the primer acceptor site, can inhibit both primer translocation and in situ priming. Lastly, we show that mutations within DR2 can result in a reduction in the synthesis of minus-strand DNA and that this reduction is occurring at an early phase of the process. We speculate that this reduction in the amount of minus-strand DNA synthesized could be due to an inhibition of the template switch during minus-strand DNA synthesis.
本研究的最初目的是检测正链引物与负链DNA模板之间的互补性在嗜肝DNA病毒复制过程中对正链引物易位的作用。我们发现,当在DR1或DR2中进行5个核苷酸的替换时,引物在可检测水平上的易位并未发生。在DR1和DR2中同时引入突变也不能恢复引物易位,这表明互补性并非引物易位的唯一决定因素。这些抑制了引物易位的突变体还提供了额外的信息。DR1中的突变导致正链DNA的有效合成,尽管是原位引发。相反,DR2中的突变导致每单位负链DNA合成的正链DNA量减少。这些发现被解释为表明引物接受位点DR2处的突变可同时抑制引物易位和原位引发。最后,我们表明DR2内的突变可导致负链DNA合成减少,且这种减少发生在该过程的早期阶段。我们推测,负链DNA合成量的这种减少可能是由于负链DNA合成过程中模板转换受到抑制所致。